Search - tctmd.com

Displaying 61 - 80 of 94

Sort: Relevancy | Date

News Conference News AHA 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Michael O'Riordan

November 10, 2018

News Daily News

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Michael O'Riordan

November 01, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2018

Shelley Wood

October 31, 2018

News Features

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Shelley Wood

October 22, 2018

News Opinion Off Script TCT 2018

Off Script: Phantom Hearts and the Elusive Nature of Angina

Kwan S. Lee

October 11, 2018

Presentation TCT 2018

Diversity in the Interventional Workplace: Current Challenges and Opportunities

Presenter: Wayne B. Batchelor, Aaron Horne, Jr., Roxana Mehran

September 24, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Conference News EuroPCR 2018

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

Michael O'Riordan

May 23, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

News Daily News

Healthcare Spending on the Rise for Working-Age Adults With Hypertension

Todd Neale

March 07, 2018

News Conference News CRT 2018

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Michael O'Riordan

March 05, 2018

News Features

Cardiologists Treating Syrian Refugees Call Missions an ‘Addictive’ Passion That Saves Lives

Yael L. Maxwell

January 12, 2018

News Conference News AHA 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Michael O'Riordan

November 13, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Daily News

Long-term Ticagrelor Post-MI of ‘Intermediate Value’: Cost-Effectiveness Study

Leah Lawrence

July 24, 2017

News Features

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

Michael O'Riordan

May 23, 2017

News Industry News

New Data from PLATINUM Diversity Study Presented at SCAI 2017 Provide Important Insights Beyond Traditional Clinically-Reported Endpoints

May 12, 2017

News Features

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Michael O'Riordan

May 08, 2017

News Daily News

Conflicting Results: Personal Financial Ties Among Investigators Linked to Positive Trial Findings

Shelley Wood

January 19, 2017

News Daily News

Conflicts of Interest in the 2013 Cholesterol Guidelines? New Analysis Revisits the Controversy

Caitlin E. Cox

January 17, 2017

Advertisement

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

TCTMD’s Top 10 Most Popular Stories for October 2018

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Off Script: Phantom Hearts and the Elusive Nature of Angina

Diversity in the Interventional Workplace: Current Challenges and Opportunities

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Healthcare Spending on the Rise for Working-Age Adults With Hypertension

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Cardiologists Treating Syrian Refugees Call Missions an ‘Addictive’ Passion That Saves Lives

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Long-term Ticagrelor Post-MI of ‘Intermediate Value’: Cost-Effectiveness Study

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

New Data from PLATINUM Diversity Study Presented at SCAI 2017 Provide Important Insights Beyond Traditional Clinically-Reported Endpoints

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Conflicting Results: Personal Financial Ties Among Investigators Linked to Positive Trial Findings

Conflicts of Interest in the 2013 Cholesterol Guidelines? New Analysis Revisits the Controversy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content